91 related articles for article (PubMed ID: 24632201)
1. FoxD3 deficiency promotes breast cancer progression by induction of epithelial-mesenchymal transition.
Chu TL; Zhao HM; Li Y; Chen AX; Sun X; Ge J
Biochem Biophys Res Commun; 2014 Apr; 446(2):580-4. PubMed ID: 24632201
[TBL] [Abstract][Full Text] [Related]
2. FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer.
Wang QS; Kong PZ; Li XQ; Yang F; Feng YM
Breast Cancer Res; 2015 Feb; 17(1):30. PubMed ID: 25848863
[TBL] [Abstract][Full Text] [Related]
3. FOXF2 suppresses the FOXC2-mediated epithelial-mesenchymal transition and multidrug resistance of basal-like breast cancer.
Cai J; Tian AX; Wang QS; Kong PZ; Du X; Li XQ; Feng YM
Cancer Lett; 2015 Oct; 367(2):129-37. PubMed ID: 26210254
[TBL] [Abstract][Full Text] [Related]
4. FOXD3 is a novel tumor suppressor that affects growth, invasion, metastasis and angiogenesis of neuroblastoma.
Li D; Mei H; Qi M; Yang D; Zhao X; Xiang X; Pu J; Huang K; Zheng L; Tong Q
Oncotarget; 2013 Nov; 4(11):2021-44. PubMed ID: 24269992
[TBL] [Abstract][Full Text] [Related]
5. The dual role of FOXF2 in regulation of DNA replication and the epithelial-mesenchymal transition in breast cancer progression.
Lo PK; Lee JS; Liang X; Sukumar S
Cell Signal; 2016 Oct; 28(10):1502-19. PubMed ID: 27377963
[TBL] [Abstract][Full Text] [Related]
6. FOXD3 suppresses epithelial-mesenchymal transition through direct transcriptional promotion of SMAD7 in esophageal squamous cell carcinoma.
Wu Z; Li Y; Niu Y; Lu J; Yan Z; Xu T; Guo Y; Dong Z; Guo W
Mol Carcinog; 2021 Dec; 60(12):859-873. PubMed ID: 34551139
[TBL] [Abstract][Full Text] [Related]
7. SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression.
Zhang J; Liang Q; Lei Y; Yao M; Li L; Gao X; Feng J; Zhang Y; Gao H; Liu DX; Lu J; Huang B
Cancer Res; 2012 Sep; 72(17):4597-608. PubMed ID: 22787120
[TBL] [Abstract][Full Text] [Related]
8. FOXD3 regulates anaplastic thyroid cancer progression.
Yin H; Meng T; Zhou L; Zhao F; Li X; Li Y; Hu M; Chen H; Song D
Oncotarget; 2017 May; 8(20):33644-33651. PubMed ID: 28430585
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition.
Lv ZD; Kong B; Li JG; Qu HL; Wang XG; Cao WH; Liu XY; Wang Y; Yang ZC; Xu HM; Wang HB
Oncol Rep; 2013 Jan; 29(1):219-25. PubMed ID: 23129177
[TBL] [Abstract][Full Text] [Related]
10. 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.
Tsai JH; Hsu LS; Lin CL; Hong HM; Pan MH; Way TD; Chen WJ
Toxicol Appl Pharmacol; 2013 Nov; 272(3):746-56. PubMed ID: 23921149
[TBL] [Abstract][Full Text] [Related]
11. Hepatoma-derived growth factor regulates breast cancer cell invasion by modulating epithelial--mesenchymal transition.
Chen SC; Kung ML; Hu TH; Chen HY; Wu JC; Kuo HM; Tsai HE; Lin YW; Wen ZH; Liu JK; Yeh MH; Tai MH
J Pathol; 2012 Oct; 228(2):158-69. PubMed ID: 22247069
[TBL] [Abstract][Full Text] [Related]
12. Short hairpin RNA targeting FOXQ1 inhibits invasion and metastasis via the reversal of epithelial-mesenchymal transition in bladder cancer.
Zhu Z; Zhu Z; Pang Z; Xing Y; Wan F; Lan D; Wang H
Int J Oncol; 2013 Apr; 42(4):1271-8. PubMed ID: 23403865
[TBL] [Abstract][Full Text] [Related]
13. Forkhead Box F1 promotes breast cancer cell migration by upregulating lysyl oxidase and suppressing Smad2/3 signaling.
Nilsson G; Kannius-Janson M
BMC Cancer; 2016 Feb; 16():142. PubMed ID: 26908052
[TBL] [Abstract][Full Text] [Related]
14. FOXD3 suppresses tumor growth and angiogenesis in non-small cell lung cancer.
Yan JH; Zhao CL; Ding LB; Zhou X
Biochem Biophys Res Commun; 2015 Oct; 466(1):111-6. PubMed ID: 26341266
[TBL] [Abstract][Full Text] [Related]
15. Modulation of FOXD3 activity in human embryonic stem cells directs pluripotency and paraxial mesoderm fates.
Arduini BL; Brivanlou AH
Stem Cells; 2012 Oct; 30(10):2188-98. PubMed ID: 22887036
[TBL] [Abstract][Full Text] [Related]
16. Low doses ionizing radiation enhances the invasiveness of breast cancer cells by inducing epithelial-mesenchymal transition.
Zhang X; Li X; Zhang N; Yang Q; Moran MS
Biochem Biophys Res Commun; 2011 Aug; 412(1):188-92. PubMed ID: 21810413
[TBL] [Abstract][Full Text] [Related]
17. Fascin, an actin-bundling protein, promotes breast cancer progression in vitro.
Xing P; Li JG; Jin F; Zhao TT; Liu Q; Dong HT; Wei XL
Cell Biochem Funct; 2011 Jun; 29(4):303-10. PubMed ID: 21491467
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of integrin-linked kinase correlates with malignant phenotype in non-small cell lung cancer and promotes lung cancer cell invasion and migration via regulating epithelial-mesenchymal transition (EMT)-related genes.
Chen D; Zhang Y; Zhang X; Li J; Han B; Liu S; Wang L; Ling Y; Mao S; Wang X
Acta Histochem; 2013 Mar; 115(2):128-36. PubMed ID: 22683084
[TBL] [Abstract][Full Text] [Related]
19. FoxD3 regulates cranial neural crest EMT via downregulation of tetraspanin18 independent of its functions during neural crest formation.
Fairchild CL; Conway JP; Schiffmacher AT; Taneyhill LA; Gammill LS
Mech Dev; 2014 May; 132():1-12. PubMed ID: 24582980
[TBL] [Abstract][Full Text] [Related]
20. RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis.
Palafox M; Ferrer I; Pellegrini P; Vila S; Hernandez-Ortega S; Urruticoechea A; Climent F; Soler MT; Muñoz P; Viñals F; Tometsko M; Branstetter D; Dougall WC; González-Suárez E
Cancer Res; 2012 Jun; 72(11):2879-88. PubMed ID: 22496457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]